Jon S Saxe

Jon S Saxe has an estimated net worth of $5.74 Million. This is based on reported shares across multiple companies, which include FIRST HORIZON PHARMACEUTICAL CORP, Vistagen Therapeutics, Inc., DURECT CORP, INSITE VISION INC, PDL BIOPHARMA, INC., QUESTCOR PHARMACEUTICALS INC, SCICLONE PHARMACEUTICALS INC, and INCYTE CORP.

2007 was Jon S Saxe's most active year for acquiring shares with 19 total transactions. Jon S Saxe's most active month to acquire stocks was the month of May. 2006 was Jon S Saxe's most active year for disposing of shares, totalling 29 transactions. Jon S Saxe's most active month to dispose stocks was the month of February. 2008 saw Jon S Saxe paying a total of $2,054,992.00 for 343,750 shares, this is the most they've acquired in one year. In 2017 Jon S Saxe cashed out on 435,000 shares for a total of $3,025,200.00, their largest year based on trade value.